ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 883.00K | 1.25M | 1.43M | 1.49M | 1.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 883.00K | 1.25M | 1.43M | 1.49M | 1.42M |
| Cost of Revenue | 1.01M | 513.00K | 905.00K | 1.64M | 1.20M |
| Gross Profit | -123.00K | 734.00K | 526.00K | -150.00K | 215.00K |
| SG&A Expenses | 4.64M | 4.62M | 4.09M | 17.08M | 6.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.65M | 5.14M | 5.09M | 18.78M | 7.90M |
| Operating Income | -4.76M | -3.89M | -3.66M | -17.29M | -6.48M |
| Income Before Tax | -7.00M | -3.69M | -4.68M | -19.02M | -7.47M |
| Income Tax Expenses | -157.00K | 779.00K | -- | 14.56M | -2.51M |
| Earnings from Continuing Operations | -6.84M | -4.47M | -4.68M | -33.57M | -4.97M |
| Earnings from Discontinued Operations | -- | -- | 8.64M | -786.00K | -1.62M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.84M | -4.47M | 3.97M | -34.36M | -6.59M |
| EBIT | -4.76M | -3.89M | -3.66M | -17.29M | -6.48M |
| EBITDA | -3.73M | -2.55M | -2.18M | -15.77M | -4.96M |
| EPS Basic | -0.16 | -0.11 | 0.11 | -1.59 | -0.35 |
| Normalized Basic EPS | -0.11 | -0.04 | -0.08 | -0.50 | -0.24 |
| EPS Diluted | -0.16 | -0.11 | 0.11 | -1.59 | -0.35 |
| Normalized Diluted EPS | -0.11 | -0.04 | -0.08 | -0.50 | -0.24 |
| Average Basic Shares Outstanding | 41.54M | 41.54M | 35.23M | 20.46M | 19.08M |
| Average Diluted Shares Outstanding | 41.54M | 41.54M | 35.23M | 20.46M | 19.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |